Constance F. Ramos, PhD, Esq.

EDUCATION

  • Juris Doctor, University of California, Berkeley, School of Law (Boalt Hall)         
  • PhD Biophysics, University of California, Berkeley
  • AB Physics and Computer Science, University of California, Berkeley

BAR ADMISSIONS

  • California
  • UK Solicitor, England & Wales 
  • United States Patent & Trademark Office

Constance F. Ramos received her AB in Physics and Computer Science (1983) and her PhD in Biophysics (1989) from the University of California, Berkeley.  She received her Juris Doctor from the University of California, Berkeley School of Law (Boalt Hall) in 1999.  Prior to founding AKIRA IP, Constance was a partner at several multi-national law firms in the San Francisco Bay Area.  For nearly 20 years, Constance’s IP practice has involved a variety of high technology innovations, including:  solid state lighting and other semiconductor devices; RFID technologies; medical devices; robotics; computer software and hardware; modern telephony and networking technologies; cryptography; and related industries, including computer industry standards.  


Before law school, Constance was a research scientist focusing on mathematical modeling and computer simulations of biological control systems. She has held postdoctoral positions at The Rockefeller University, NASA Ames Research Center, and the University of California at Berkeley as a UC President’s Fellow.  She was also the Department Chair and Professor of Computer Information Systems at Merritt College in Oakland, California.


Constance’s prior academic research background, coupled with her extensive experience as a patent litigator and IP transactions attorney in large, multi-national law firms, establish her legal expertise and acumen in intellectual property and technology law.  Her trial and litigation experience—primarily in patent, trade secrets, and high technology contract disputes—makes her exceptionally qualified to advise clients in complex IP transactional matters, in a broad range of industry sectors and technologies.  


Constance is admitted in California, the U.S. Patent and Trademark Office, and England & Wales (Solicitor). She is also admitted to practice before the Federal Circuit and US Supreme Court, as well as numerous federal district courts.

Representative IP Transactional Matters

  • Strategic patent portfolio evaluation in the robotics industry.
  • Evaluation of a U.S. patent portfolio held by a university relating to medical treatments, for potential acquisition.
  • Preparation of intellectual property licenses, joint development agreements, nondisclosure agreements, and service agreements in a variety of industries, including automotive and medical device industries.
  • Evaluation of software licenses relating to real-time computing technologies.
  • IP due diligence on behalf of a service provider in connection with its acquisition by a large Internet Service Provider.
  • IP due diligence on behalf of a mobile data software and services company in connection with its acquisition of a telecommunications software developer.

Representative IP Litigation Matters

  • Representation of a semiconductor chip design house accused of breach of contract, trade secret misappropriation, and various other alleged torts.
  • Representation of a networking device company in a matter involving allegations of patent infringement concerning the “Power-over-Ethernet” industry standard. 
  • Representation of a  semiconductor technology developer and patent owner in various patent linfringement matters.
  • Representation of a high-power LED company against its competitor in a series of patent infringement cases involving five LED patents.
  • Representation of a networking device company in separate litigation matters on patent infringement claims involving patented voice-over IP technology.
  • Representation of a networking device company against allegations of patent infringement in the field of telecommunications.
  • Representation of a pharmaceutical company in products liability litigation involving allegations of adverse reactions to a common OTC medication.